Literature DB >> 15598790

Effects of alcohol and menstrual cycle on insulin-like growth factor-I and insulin-like growth factor binding protein-3.

Jackie A Lavigne1, Heather H Wimbrow, Beverly A Clevidence, Paul S Albert, Marsha E Reichman, William S Campbell, J Carl Barrett, Stephen D Hursting, Joseph T Judd, Philip R Taylor.   

Abstract

Alcohol ingestion and insulin-like growth factor-I (IGF-I) have been associated with increased breast cancer risk, the latter primarily in premenopausal women. We investigated whether alcohol ingestion altered IGF-I or its major binding protein (BP), IGFBP-3, in a controlled feeding study in premenopausal women. We also determined whether IGF-I or IGFBP-3 was affected by menstrual cycle phase. Serum was collected from 31 individuals who were randomly assigned to consume either 0 or 30 g (two drinks) of alcohol daily for three menstrual cycles and who then crossed over to the other alcohol level for three cycles. All calories were provided and weight was maintained during the study. For both alcohol levels, serum was collected during the final cycle at early follicular, periovulatory, and luteal phases. Relative to the follicular phase, IGF-I levels increased by 3.3% and 7.6% in the periovulatory and luteal phases, respectively (P for trend = 0.004). Although alcohol ingestion did not affect this increase, it significantly reduced IGF-I concentrations at all phases (9.5%; P < 0.001), whereas IGFBP-3 was unaffected by either menstrual phase or alcohol. This is the first controlled diet study to show that alcohol decreases serum IGF-I in premenopausal women and that IGF-I significantly increases over the course of the menstrual cycle whether or not alcohol is present.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15598790

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  5 in total

1.  Race/ethnic variation in serum levels of IGF-I and IGFBP-3 in US adults.

Authors:  David Berrigan; Nancy Potischman; Kevin W Dodd; Stephen D Hursting; Jackie Lavigne; J Carl Barrett; Rachel Ballard-Barbash
Journal:  Growth Horm IGF Res       Date:  2008-09-21       Impact factor: 2.372

2.  Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies.

Authors:  Timothy J Key; Paul N Appleby; Gillian K Reeves; Andrew W Roddam
Journal:  Lancet Oncol       Date:  2010-05-14       Impact factor: 41.316

3.  A cross-sectional study of different patterns of oral contraceptive use among premenopausal women and circulating IGF-1: implications for disease risk.

Authors:  Kristina M Blackmore; Jody Wong; Julia A Knight
Journal:  BMC Womens Health       Date:  2011-05-20       Impact factor: 2.809

4.  Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease.

Authors:  Hisani N Horne; Mark E Sherman; Ruth M Pfeiffer; Jonine D Figueroa; Zeina G Khodr; Roni T Falk; Michael Pollak; Deesha A Patel; Maya M Palakal; Laura Linville; Daphne Papathomas; Berta Geller; Pamela M Vacek; Donald L Weaver; Rachael Chicoine; John Shepherd; Amir Pasha Mahmoudzadeh; Jeff Wang; Bo Fan; Serghei Malkov; Sally Herschorn; Stephen M Hewitt; Louise A Brinton; Gretchen L Gierach
Journal:  Breast Cancer Res       Date:  2016-02-18       Impact factor: 6.466

5.  Does the timing of breast cancer surgery in pre-menopausal women affect clinical outcome? An update.

Authors:  Anushka Chaudhry; Michael L Puntis; Panos Gikas; Kefah Mokbel
Journal:  Int Semin Surg Oncol       Date:  2006-11-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.